Safety profile of parenteral meglumine antimoniate (Glucantime®) in infants treated for cutaneous leishmaniasis

被引：0
|
作者：
Frikha, Fatma [1 ]
Boudaya, Sonia [1 ]
Bahloul, Emna [1 ]
Amouri, Meriem [1 ]
Turki, Hamida [1 ]
机构：
[1] Hop Hedi Chaker, Serv Dermatol Venereol, Ave Ain, Sfax 3089, Tunisia
来源：
THERAPIE | 2020年 / 75卷 / 03期
关键词：
Cutaneous leishmaniasis; Glucantime; Meglumine antimoniate; Side effects; Infant; Children; HIGH-FREQUENCY; CHILDREN; PHARMACOKINETICS;
D O I：
10.1016/j.therap.2019.05.001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：314 / 316
页数：4
相关论文
共 50 条
  • [1] Safety profile of meglumine antimoniate intralesional infiltration for cutaneous leishmaniasis
    Fernandes, Herbert J.
    da Silva, Rosiana E.
    Ramalho, Dario B.
    Aguiar, Marta G.
    Silveira, Josiane N.
    Cota, Glaucia
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2020, 18 (04) : 381 - 387
  • [2] Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis
    Esfandiarpour, I
    Alavi, A
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2002, 41 (08) : 521 - 524
  • [3] Glucantime Fever with Parenteral Meglumine Antimonate in Patients of Cutaneous Leishmaniasis
    Dar, Nasser Rashid
    Tabassum, Sadia
    Rao, Sibghat Ullah
    Masood, Sadia
    Abbas, Muhammad
    Mumtaz, Jauhar
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2010, 20 (07): : 496 - 496
  • [4] Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis
    Layegh, Pouran
    Yazdanpanah, Mohammad Javad
    Vosugh, Elham Mohammadi
    Pezeshkpoor, Fakhrozaman
    Shakeri, Mohamad Taghi
    Moghiman, Toktam
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (01): : 99 - 101
  • [5] Efficacy of Cryotherapy versus Intralesional Meglumine Antimoniate (Glucantime) for Treatment of Cutaneous Leishmaniasis in Children
    Layegh, Pouran
    Pezeshkpoor, Fakhrozaman
    Soruri, Amir Hossein
    Naviafar, Parisa
    Moghiman, Toktam
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2009, 80 (02): : 172 - 175
  • [6] Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime®) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime®) alone for the treatment of cutaneous leishmaniasis
    Asilian, A
    Sadeghinia, A
    Faghihi, G
    Momeni, A
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2004, 43 (04) : 281 - 283
  • [7] Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis
    Arevalo, Iracema
    Tulliano, Gianfranco
    Quispe, Ana
    Spaeth, Gerald
    Matlashewski, Greg
    Llanos-Cuentas, Alejandro
    Pollack, Henry
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (12) : 1549 - 1554
  • [8] Retrospective study of 151 patients with cutaneous leishmaniasis treated with meglumine antimoniate
    Schubach, AD
    Marzochi, KBF
    Moreira, JS
    Schubach, TMP
    Araújo, ML
    do Vale, ACF
    Passos, SRL
    Marzochi, MCD
    [J]. REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2005, 38 (03) : 213 - 217
  • [9] Intralesional treatment of cutaneous leishmaniasis with meglumine antimoniate
    Aste, N
    Pau, M
    Ferreli, C
    Biggio, P
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1998, 138 (02) : 370 - 371
  • [10] Comparison of Meglumine Antimoniate and Miltefosine in Cutaneous Leishmaniasis
    Rahman, Atiya
    Tahir, Moizza
    Naveed, Tehseen
    Abdullah, Mohammad
    Qayyum, Nida
    Malik, Danish Hafeez
    Amin, Bushra
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2023, 33 (12): : 1367 - 1371
12345